Header Logo

Connection

Lee Fairlie to Vaccines

This is a "connection" page, showing publications Lee Fairlie has written about Vaccines.
Connection Strength

0,781
  1. Obstetric and neonatal outcomes in South Africa. Vaccine. 2024 Feb 27; 42(6):1352-1362.
    View in: PubMed
    Score: 0,206
  2. ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nat Immunol. 2023 07; 24(7):1161-1172.
    View in: PubMed
    Score: 0,197
  3. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa. AIDS. 2023 01 01; 37(1):105-112.
    View in: PubMed
    Score: 0,189
  4. Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial. Lancet Infect Dis. 2023 03; 23(3):295-306.
    View in: PubMed
    Score: 0,189
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.